In a large German multicenter study it was concluded that CD8+ tumor infiltrating lymphocytes constitute an independent prognostic marker in HNSCC patients treated with adjuvant chemoradiotherapy and can potentially be used for patient stratification [48]. Here, CD8A is linked to head and neck squamous cell carcinoma.